Can Cephalon get any more cynical? Another Provigil price hike leaves patients out in the cold.
Members of Prescirption Access Litigation's coalition are plaintiffs in a national class action lawsuit that alleges the Cephalon (Nasdaq:CEPH) illegally took steps to keep a less expensive generic version of its narcolepsy drug Provigil off the market, i
Director of PAL coalition member elected to California county office
We here at Prescription Access Litigation (PAL) are pleased to congratulate Shirlee Zane, the Executive Director of the Council on Aging of Sonoma County (CA), on her recent election to be the Sonoma County Supervisor for the Third District. The Council
National Women's Health Network says: Don't Be Fooled by OvaSure
Prescription Access Litigation coalition member National Women's Health Network recently sent a news item about the FDA's September 29 letter to LabCorp, advising it that its ovarian cancer screening test is a medical device that must be pre-approved by
1st Circuit upholds New Hampshire's ban on pharmacy datamining
Today, the 1st Circuit Court of Appeals issued a decision in IMS v. Ayotte, the case challenging New Hampshire’s Prescription Confidentiality Act, which prohibits the commercial use of prescriber data, including for pharmaceutical detailing. The Court un
U.S. First Circuit Court of Appeals upholds New Hampshire data-mining law
Today the First Circuit Court of Appeals unanimously upheld New Hampshire’s Prescription Confidentiality Act, which prohibits the commercial use of prescriber data, including for pharmaceutical detailing.
The practice, commonly known as “data-mining,” is
Rx Futures
In the afterglow (or for some, aftermath) of the election, PostScript thought it was worth scanning the federal policy horizon for any Rx out there.
And it’s hard to say anything about prescription drug policy in the next Congress without first talking ab
CVS & Rite-Aid's new NY translation services - what happens when something goes wrong?
We noted this Newsday story with pleasure: "2 drug chains to provide Rx translation services," about an agreement between NY Attorney General Andrew Cuomo and the pharmacy chains CVS (NYSE:CVS) & Rite-Aid (NYSE:RAD). Says the article:
CVS and Rite-Aid,
PAL member Change to Win challenges CVS Caremark's pushing Merck's Januvia to Docs
David Armstrong reports in today's Wall Street Journal that Change to Win, a member of the Prescription Access Litigation coalition, is launching campaign to challenge CVS Caremark's [NYSE:CVS] sending of a letter to doctors of specific patients, apparen
Preemption: The Movie! Alliance for Justice's "Access Denied"
The good folks over at Alliance for Justice are premiering a new 22-minute documentary about Diana Levine, the Vermont musician who lost her forearm to gangrene caused by a prescription drug made by Wyeth, and whose suit against Wyeth has gone all the way